UK and EU Competition Currents February 2022
UK CMA continues to focus on competitor collusion to increase the prices of pharmaceuticals supplied to the UK NHS by imposing fines totaling £35 million on four pharmaceutical firms and their parent companies, EC withholds default interest from Deutsche Telekom and more.
Source: natlawreview.com